Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2024 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Jul 25, 2024
Slide 1: Supplementary Slides Q2 2024
SUPPLEMENTARY SLIDES Q2 2024 For the periods ended June 15, 2024 and June 17, 2023 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q2 2024 (millions of Canadian dollars unless otherwise noted) Q2 2024 Q2 2023 % Change (1) Consolidated Revenue $13,947 $13,738 ↑ +1.5% Adjusted EBITDA $1,713 $1,640 ↑ +4.5% Adjusted EBITDA Margin 12.3 % 11.9 % ↑ 40bps Adjusted Net Earnings Avaliable to Common Sh
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q2 2024 (millions of Canadian dollars unless otherwise noted) Q2 2024 Q2 2023 % Change (1) Total Retail Revenue $13,658 $13,471 ↑ 1.4% Retail Revenue - Food $9,653 $9,560 ↑ 1.0% Retail Revenue - Drug $4,005 $3,911 ↑ 2.4% Pharmacy and Healthcare Services $2,110
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q2 2024 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +0.2% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +1.5